Babyo2
NDC Package 72136-007-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Babyo2 is change wet and solid diapers promptly. Marketed by Oxigenesis, Inc., this product is identified by NDC 72136-007.

Identification & Billing

NDC Package Code
72136-007-01
Package Description
240 mL in 1 TUBE
Product Code
72136-007
11-Digit Billing Format
72136000701

Clinical Specifications

Proprietary Name
Babyo2
Dosage Form
-
Usage Information
Change wet and solid diapers promptly. Cleanse diaper area and dry. Apply serum liberally as often necessary with every diaper change, especially at bedtime.Other informationStore at 20°-25°C (68° -70° F)

Regulatory & Marketing

Labeler Name
Oxigenesis, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
09-20-2020
Listing Expiration
12-31-2021
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 72136-007-01 identifies a specific commercial package of 240 ml in 1 tube of Babyo2, labeled by Oxigenesis, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Oxigenesis, Inc. on September 20, 2020. The current certification is valid through December 31, 2021.

How is this Oxigenesis, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 72136000701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
72136-007-01
11-Digit CMS (5-4-2)
72136-0007-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.